Coombes lab begins research collaboration with Qu Biologics

January 31, 2014

Vancouver, British Columbia - Qu Biologics Inc. is a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the body’s immune system against autoimmune diseases and cancer. The Coombes lab is pleased to be working with Qu Biologics to study a new Crohn’s disease research model. The partnership was recently featured in BioTechnology Focus. 




Please reload

Featured Posts

McMaster names University Scholars

June 28, 2016

Please reload

Recent Posts

September 11, 2019

May 22, 2019

May 16, 2019

Please reload